RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Oper ...
Takeda made it rain zebras at a Boston Celtics game Friday. The stunt saw 100 toy zebras parachute from the arena’s rafters ...
Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen ...
Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Welcome to Definitive Healthcare’s Q4 2024 Earnings Call.
After the dust settled on "Chikhai Bardo"—which sent every Severance fan's Innie and Outie into a tailspin—I saw that episode ...
Announces several updates to enhance and accelerate AXPAXLI registrational program in wet AMD, potentially supporting label ...
If you suffered losses exceeding $50,000 in ESSA Pharma between December 12, 2023 and October 31, 2024 and would like to ...
NEW YORK, NY / ACCESS Newswire / March 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback